Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 188

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 188
---
                          |           - |   |     |                            |        - |   |     |                        | (45,455,950 | ) |     | 3(B) |     |             |           - |   |     |      |     |                    |           - |   |
|                                                      |     |                             |           - |   |     |                          |           - |   |     |                            |        - |   |     |                        |           - |   |     |      |     |             |  16,852,551 |   |     | 3(D) |     |                    |           - |   |
| Total shareholders'/members' deficit                 |     |                             | (10,651,148 | ) |     |                          |  (1,451,874 | ) |     |                            | (179,350 | ) |     |                        |           - |   |     |      |     |             |   8,903,419 |   |     |      |     |                    |  (3,378,953 | ) |
| Total liabilities and shareholders'/members' deficit |     | $                           |      24,193 |   |     | $                        |     487,609 |   |     | $                          |   41,795 |   |     | $                      |           - |   |     |      |     | $           |     355,500 |   |     |      |     | $                  |     909,097 |   |

<div align='center'>The accompanying notes are an integral part of these financial statements.</div>

| 85 |

<div align='center'>UNAUDITED
PRO FORMA COMBINED LONGEVITY

STATEMENT OF OPERATIONS FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2024</div>

| Operating expenses                                |     | Longevity Biomedical, Inc. Historical |            |   |     | Cerevast Medical, Inc. Historical |            |   |     | Aegeria Soft Tissue LLC Historical |           |   |     | Transaction Accounting Adjustments |            |   |     | Notes |     | Pro Forma Combined Longevity |            |   |
|:--------------------------------------------------|:----|:--------------------------------------|-----------:|:--|:----|:----------------------------------|-----------:|:--|:----|:-----------------------------------|----------:|:--|:----|:-----------------------------------